Trials / Completed
CompletedNCT01565291
A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers
A Preliminary Evaluation of the Amyloid Binding Properties, Pharmacokinetics and Safety of 18F-AV-45 in Healthy Elderly Volunteers and Patients With Alzheimer's Disease
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
A preliminary study to test how florbetapir F 18 (18F-AV-45) acts in the brains and bodies of healthy elderly people and patients with Alzheimer's Disease (AD) by using a positron emission tomography (PET) scanner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | florbetapir F 18 | IV injection, 370MBq (10mCi), single dose |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2012-03-28
- Last updated
- 2012-05-18
- Results posted
- 2012-05-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01565291. Inclusion in this directory is not an endorsement.